Report Summary
Eternity Insights has published a new study on Global DNA Vaccines Market focusing on key segments as by Type (Recombinant Protein Vaccine,Gene-Based Vaccine, Other), by Application (Influenza,Human Papillomavirus,HIV, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global DNA Vaccines Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
DNA Vaccines Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global DNA Vaccines Market Size, 2018-2028 (USD Million)
To learn more about this report
Global DNA Vaccines Market Segmentation:
DNA Vaccines Market, By Type
- Recombinant Protein Vaccine
- Gene-Based Vaccine
- Other
DNA Vaccines Market, By Application
- Influenza
- Human Papillomavirus
- HIV
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global DNA Vaccines market in terms of demand generation. The DNA Vaccines market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for DNA Vaccines market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global DNA Vaccines Market Taxonomy:
To learn more about this report
Global DNA Vaccines Market Competitive Landscape
The global DNA Vaccines market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Merck
- GSK
- Sanofi
- Zoties
- Elanco
- Boehringer-Ingelheim
- Indian Immunologicals
- Plumbline Life Sciences
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Recombinant Protein Vaccine,Gene-Based Vaccine, Other |
| By Application Outlook |
Influenza,Human Papillomavirus,HIV, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Merck,GSK,Sanofi,Zoties,Elanco,Boehringer-Ingelheim,Indian Immunologicals,Plumbline Life Sciences |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global DNA Vaccines Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 DNA Vaccines Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 DNA Vaccines Industry Overview
2.1 Global DNA Vaccines Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 DNA Vaccines Global Import Market Analysis
2.1.2 DNA Vaccines Global Export Market Analysis
2.1.3 DNA Vaccines Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Recombinant Protein Vaccine
2.2.2 Gene-Based Vaccine
2.3.2 Human Papillomavirus
2.3.3 HIV
2.4.2 Global DNA Vaccines Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global DNA Vaccines Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 DNA Vaccines Manufacturer Market Share
2.4.5 Top 10 DNA Vaccines Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into DNA Vaccines Market
2.4.7 Key Manufacturers DNA Vaccines Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 DNA Vaccines Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 DNA Vaccines Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global DNA Vaccines Market Size Categorized by Regions
4.1 Global DNA Vaccines Revenue, Sales and Market Share by Regions
4.1.1 Global DNA Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global DNA Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 Europe DNA Vaccines Sales and Growth Rate (2015-2020)
4.3 APAC DNA Vaccines Sales and Growth Rate (2015-2020)
4.4 North America DNA Vaccines Sales and Growth Rate (2015-2020)
4.5 South America DNA Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa DNA Vaccines Sales and Growth Rate (2015-2020)
5 Europe DNA Vaccines Market Size Categorized by Countries
5.1 Europe DNA Vaccines Sales, Revenue and Market Share by Countries
5.1.1 Europe DNA Vaccines Sales by Countries (2015-2020)
5.1.2 Europe DNA Vaccines Revenue by Countries (2015-2020)
5.1.3 Germany DNA Vaccines Sales and Growth Rate (2015-2020)
5.1.4 UK DNA Vaccines Sales and Growth Rate (2015-2020)
5.1.5 France DNA Vaccines Sales and Growth Rate (2015-2020)
5.1.6 Russia DNA Vaccines Sales and Growth Rate (2015-2020)
5.1.7 Italy DNA Vaccines Sales and Growth Rate (2015-2020)
5.1.8 Spain DNA Vaccines Sales and Growth Rate (2015-2020)
5.2 Europe DNA Vaccines Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe DNA Vaccines Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe DNA Vaccines Sales Market Share by Type (2015-2020)
5.3.2 Europe DNA Vaccines Revenue and Revenue Share by Type (2015-2020)
5.4 Europe DNA Vaccines Sales Market Share by Application (2015-2020)
6 Asia-Pacific DNA Vaccines Market Size Categorized by Countries
6.1 Asia-Pacific DNA Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific DNA Vaccines Sales by Countries (2015-2020)
6.1.2 Asia-Pacific DNA Vaccines Revenue by Countries (2015-2020)
6.1.3 China DNA Vaccines Sales and Growth Rate (2015-2020)
6.1.4 Japan DNA Vaccines Sales and Growth Rate (2015-2020)
6.1.5 Korea DNA Vaccines Sales and Growth Rate (2015-2020)
6.1.6 India DNA Vaccines Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia DNA Vaccines Sales and Growth Rate (2015-2020)
6.1.8 Australia DNA Vaccines Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific DNA Vaccines Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific DNA Vaccines Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific DNA Vaccines Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific DNA Vaccines Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific DNA Vaccines Sales and Market Share by Application (2015-2020)
7 North America DNA Vaccines Market Size Categorized by Countries
7.1 North America DNA Vaccines Sales, Revenue and Market Share by Countries
7.1.1 North America DNA Vaccines Sales by Countries (2015-2020)
7.1.2 North America DNA Vaccines Revenue by Countries (2015-2020)
7.1.3 United States DNA Vaccines Sales and Growth Rate (2015-2020)
7.1.4 Canada DNA Vaccines Sales and Growth Rate (2015-2020)
7.1.5 Mexico DNA Vaccines Sales and Growth Rate (2015-2020)
7.2 North America DNA Vaccines Revenue (Value) by Manufacturers (2018-2020)
7.3 North America DNA Vaccines Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America DNA Vaccines Sales Market Share by Type (2015-2020)
7.3.2 North America DNA Vaccines Revenue and Revenue Share by Type (2015-2020)
7.4 North America DNA Vaccines Sales Market Share by Application (2015-2020)
8 South America DNA Vaccines Market Size Categorized by Countries
8.1 South America DNA Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America DNA Vaccines Sales by Countries (2015-2020)
8.1.2 South America DNA Vaccines Revenue by Countries (2015-2020)
8.1.3 Brazil DNA Vaccines Sales and Growth Rate (2015-2020)
8.2 South America DNA Vaccines Revenue (Value) by Manufacturers (2018-2020)
8.3 South America DNA Vaccines Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America DNA Vaccines Sales Market Share by Type (2015-2020)
8.3.2 South America DNA Vaccines Revenue and Revenue Share by Type (2015-2020)
8.4 South America DNA Vaccines Sales Market Share by Application (2015-2020)
9 Middle East and Africa DNA Vaccines Market Size Categorized by Countries
9.1 Middle East and Africa DNA Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa DNA Vaccines Sales by Countries (2015-2020)
9.1.2 Middle East and Africa DNA Vaccines Revenue by Countries (2015-2020)
9.1.3 GCC Countries DNA Vaccines Sales and Growth Rate (2015-2020)
9.1.4 Turkey DNA Vaccines Sales and Growth Rate (2015-2020)
9.1.5 Egypt DNA Vaccines Sales and Growth Rate (2015-2020)
9.1.6 South Africa DNA Vaccines Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa DNA Vaccines Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa DNA Vaccines Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa DNA Vaccines Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa DNA Vaccines Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa DNA Vaccines Sales Market Share by Application (2015-2020)
10 Global DNA Vaccines Market Segment by Type
10.1 Global DNA Vaccines Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global DNA Vaccines Sales and Market Share by Type (2015-2020)
10.1.2 Global DNA Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Recombinant Protein Vaccine Sales Growth Rate and Price
10.2.1 Global Recombinant Protein Vaccine Sales Growth Rate (2015-2020)
10.2.2 Global Recombinant Protein Vaccine Price (2015-2020)
10.3 Gene-Based Vaccine Sales Growth Rate and Price
10.3.1 Global Gene-Based Vaccine Sales Growth Rate (2015-2020)
10.3.2 Global Gene-Based Vaccine Price (2015-2020)
11.1 Global DNA VaccinesSales Market Share by Application (2015-2020)
11.2 Influenza Sales Growth Rate (2015-2020)
11.3 Human Papillomavirus Sales Growth Rate (2015-2020)
11.4 HIV Sales Growth Rate (2015-2020)
12.1 Global DNA Vaccines Revenue, Sales and Growth Rate (2020-2027)
12.2 DNA Vaccines Market Forecast by Regions (2020-2027)
12.2.1 Europe DNA Vaccines Market Forecast (2020-2027)
12.2.2 APAC DNA Vaccines Market Forecast (2020-2027)
12.2.3 North America DNA Vaccines Market Forecast (2020-2027)
12.2.4 South America DNA Vaccines Market Forecast (2020-2027)
12.2.5 Middle East & Africa DNA Vaccines Market Forecast (2020-2027)
12.3 DNA Vaccines Market Forecast by Type (2020-2027)
12.3.1 Global DNA Vaccines Sales Forecast by Type (2020-2027)
12.3.2 Global DNA Vaccines Market Share Forecast by Type (2020-2027)
12.4 DNA Vaccines Market Forecast by Application (2020-2027)
12.4.1 Global DNA Vaccines Sales Forecast by Application (2020-2027)
12.4.2 Global DNA Vaccines Market Share Forecast by Application (2020-2027)
13 Analysis of DNA Vaccines Industry Key Manufacturers
13.1 Merck
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Merck DNA Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Merck News
13.2 GSK
13.2.1 Company Details
13.2.2 Product Information
13.2.3 GSK DNA Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 GSK News
13.3 Sanofi
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Sanofi DNA Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Sanofi News
13.4 Zoties
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Zoties DNA Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Zoties News
13.5 Elanco
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Elanco DNA Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Elanco News
13.6 Boehringer-Ingelheim
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Boehringer-Ingelheim DNA Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Boehringer-Ingelheim News
13.7 Indian Immunologicals
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Indian Immunologicals DNA Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Indian Immunologicals News
13.8 Plumbline Life Sciences
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Plumbline Life Sciences DNA Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Plumbline Life Sciences News
15 Appendix
